Michele Tosi

Michele Tosi

Auto-generated profile, based on publicly available information

Michele Tosi

Unit of Muscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2023 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
MTMichele Tosi
Michele Tosi
FCFrancesca Cumbo
Francesca Cumbo
MCMichela Catteruccia
Michela Catteruccia
ACAdelina Carlesi
Adelina Carlesi
IMIrene Mizzoni
Irene Mizzoni
ADAdele D'Amico
Adele D'Amico

Verified
Journal Article
Open access
PDF file
PIpaola imbrici
paola imbrici
Elena ConteElena Conte
Elena Conte
Rikard BlunckRikard Blunck
Rikard Blunck
FSFabrizia Stregapede
Fabrizia Stregapede
ALAntonella Liantonio
Antonella Liantonio
GZGinevra Zanni
Ginevra Zanni
Kv1.2 channels, encoded by the KCNA2 gene, are localized in the central and peripheral nervous system, where they regulate neuronal excitability. Recently, heterozygous mutations in KCNA2 have been associated with a spectrum of symptoms extending from epileptic encephalopathy, intellectual disability, and cerebellar ataxia. Patients are treated with a combination of antiepileptic drugs and 4-aminopyridine (4-AP) has been recently trialed in specific cases. We identified a novel variant in KCNA2, E236K, in a Serbian proband with non-progressive congenital ataxia and early onset epilepsy, treated with sodium valproate. To ascertain the pathogenicity of E236K mutation and to verify its sensitivity to 4-AP, we transfected HEK 293 cells with Kv1.2 WT or E236K cDNAs and recorded potassium currents through the whole-cell patch-clamp. In silico analysis supported the electrophysiological data. E236K channels showed voltage-dependent activation shifted towards negative potentials and slower kinetics of deactivation and activation compared with Kv1.2 WT. Heteromeric Kv1.2 WT+E236K channels, resembling the condition of the heterozygous patient, confirmed a mixed gain- and loss-of-function (GoF/LoF) biophysical phenotype. 4-AP inhibited both Kv1.2 and E236K channels with similar potency. Homology modeling studies of mutant channels suggested a reduced interaction between the residue K236 in the S2 segment and the gating charges at S4. Overall, the biophysical phenotype of E236K channels correlates with the mild end of the clinical spectrum reported in patients with GoF/LoF defects. The response to 4-AP corroborates existing evidence that KCNA2-disorders could benefit from variant-tailored therapeutic approaches, based on functional studies.

30 January 2024 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
PDF file
BBBianca Buchignani
Bianca Buchignani
GCGianpaolo Cicala
Gianpaolo Cicala
FCFrancesca Cumbo
Francesca Cumbo
MRMartina Ricci
Martina Ricci
ACAnna Capasso
Anna Capasso
EMEugenio Mercuri
Eugenio Mercuri
Objective The aim of this study was to assess early language acquisitions in treated individuals with spinal muscular atrophy (SMA) type 1 and in infants identified by newborn screening (NBS). Methods Parents of SMA individuals aged between 8 and 36 months were asked to fill in the MacArthur-Bates Communicative Development Inventory (MB-CDI) that assesses comprehension, gesture and expressive skills. A follow-up assessment was performed in 21 of the 36. Results The MB-CDI was completed by parents of 24 type 1 and 12 infants identified by NBS. Comprehension skills were preserved in 81% of the type 1 SMA and in 87% infants identified by NBS. Gesture abilities were <5th centile in 55% of the type 1 SMA and in none of those identified by NBS. Lexical expressions were <5th centile in more than 80% type 1 SMA and in 50% of infants identified by NBS. At follow-up, despite an increase in lexical expression skills, the scores remained below the fifth centile in 43% type 1 SMA and in 86% of infants identified by NBS. Conclusions These results suggest that language and communication development may follow a similar pattern to that observed in motor function with the possibility to develop skills (eg, ability to say clear words) that are not usually present in untreated infants but with a level of performance that does not reach that of their typically developing peers.

14 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FTFederica Trucco
Federica Trucco
ALAndrea Lizio
Andrea Lizio
ERElisabetta Roma
Elisabetta Roma
ABAlessandra di Bari
Alessandra di Bari
FSFrancesca Salmin
Francesca Salmin
VSValeria A. Sansone
Valeria A. Sansone
Background: Sleep disorders have been poorly described in congenital (CDM) and childhood (ChDM) myotonic dystrophy despite being highly burdensome. The aims of this study were to explore sleep disorders in a cohort of Italian CDM and ChDM and to assess their association with motor and respiratory function and disease-specific cognitive and behavioral assessments. Methods: This was an observational multicenter study. Reported sleep quality was assessed using the Pediatric Daytime Sleepiness Scale (PDSS) and Pediatric Sleep Questionnaire (PSQ). Sleep quality was correlated to motor function (6 min walk test, 6MWT and grip strength; pulmonary function (predicted Forced Vital Capacity%, FVC% pred.); executive function assessed by BRIEF-2; autism traits assessed by Autism Spectrum Screening Questionnaire (ASSQ) and Repetitive Behavior Scale-revised (RBS-R); Quality of life (PedsQL) and disease burden (Congenital Childhood Myotonic Dystrophy Health Index, CCMDHI). Results: Forty-six patients were included, 33 CDM and 13 ChDM, at a median age of 10.4 and 15.1 years. Daytime sleepiness and disrupted sleep were reported by 30% children, in both subgroups of CDM and ChDM. Daytime sleepiness correlated with autism traits in CDM (p < 0.05). Disrupted sleep correlated with poorer executive function (p = 0.04) and higher disease burden (p = 0.03). Conclusions: Sleep issues are a feature of both CDM and ChDM. They correlate with behavioral issues and impact on disease burden.

3 March 2021 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
Francesco NicitaFrancesco Nicita
Francesco Nicita
LTLorena Travaglini
Lorena Travaglini
FBFrancesco Bombelli
Francesco Bombelli
MTMichele Tosi
Michele Tosi
SPStefano Pro
Stefano Pro
ADAdele D'Amico
Adele D'Amico
Objectives To report a novel association between pathogenic variants in the SEPSECS gene and complex movement disorder with thin corpus callosum (TCC). Methods Clinical exome sequencing was performed in an adult patient with a genetically unsolved neurodegenerative disorder. The main clinical, neuroimaging, and genetic data were described. Results The c.865C > T (p.P289S) and c.1297T > C (p.Y433H) missense variants in SEPSECS (NM_016,955.3) were discovered. Discussion This case represents a novel form of early-onset pyramidal syndrome with optic nerve hypoplasia, which slowly evolved to extrapyramidal syndrome featuring dystonia-parkinsonism, associated with TCC, caused by SEPSECS pathogenic variants. This form enlarges the group of the so-called pyramidal-extrapyramidal syndromes, as well as complex hereditary spastic paraparesis with TCC.

27 May 2024 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
FCFrancesca Cumbo
Francesca Cumbo
MTMichele Tosi
Michele Tosi
IMIrene Mizzoni
Irene Mizzoni
MCMichela Catteruccia
Michela Catteruccia
ACAdelina Carlesi
Adelina Carlesi
ADAdele D'AMico
Adele D'AMico